Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

9 Apr 2020 07:00

RNS Number : 2863J
Polar Capital Holdings PLC
09 April 2020
 

 

9 April 2020

Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its assets under management ("AuM") for the financial year to 31 March 2020.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2020 its AuM were £12.2bn compared to £13.8bn at the end of March 2019, a decrease of 12% over the year. In the three months ended 31 March 2020 AuM decreased by £1.9bn mainly due to the combined impact of COVID-19 and a sharp fall in oil price causing severe global equity market declines at the end of the quarter.

 

AuM movement in three months to 31 March 2020

Long-only

funds

Alternative funds

Total

AuM at

1 January 2020

£12,794m

£1,427m

£14,221m

Net redemptions

£(5)m

£(135)m

£(140)m

Market movement

and performance

£(1,711)m

£(209)m

£(1,920)m

Total AuM at

31 March 2020

£11,078m

£1,083m

£12,161m

 

 

During the 12-month period, AuM decreased by £1.7bn which comprised net outflows of £1.2bn and a decrease of £0.5bn mainly related to market movement, but mitigated by fund performance. 

 

AuM movement in twelve months to 31 March 2020

Long-only

funds

Alternative funds

Total

AuM at

1 April 2019

£12,529m

£1,306m

£13,835m

Net redemptions

£(1,137)m

£(74)m

£(1,211)m

Market movement

and performance

£(314)m

£(149)m

£(463)m

Total AuM at

31 March 2020

£11,078m

£1,083m

£12,161m

 

 

 

Gavin Rochussen, Chief Executive, commented:

 

"The coronavirus pandemic and oil price collapse brought an abrupt end to the longest bull market in history with the S&P500 declining 34% over a four-week period to its low point on 22 March. A strong rally to 31 March followed unprecedented fiscal and monetary stimulus to ensure economies and markets continued to function. Polar Capital was not immune to this equity market volatility with our AuM decreasing by £1.9bn in the March quarter alone because of market declines.

 

"Leading up to and throughout the period of lock-down as we invoked our business continuity plan and transitioned to entirely remote working it has been pleasing to witness the operational resilience of Polar Capital and its ability to continue servicing clients in a seamless manner. I am particularly pleased with the commitment of all our people, whose health and wellbeing are vitally important, as we have worked tirelessly to meet our investors' needs.

 

"The support of our fund investors, clients and other stakeholders has been comforting and we have been pleasantly surprised by the initial limited quantum of redemptions when investors were raising cash to reduce risk in their portfolios.

 

"Net outflows in the March quarter were £140m, of which £135m were from our alternative funds. Net flows were positive for the first two months of the quarter.

 

"While AuM has decreased by 12% over the year and the equity bear market means we enter our new financial year with lower average AuM than the previous year, Polar Capital continues to be cash generative and is able to utilise its significant balance sheet to meet our operational and strategic objectives.

 

"Despite market volatility in March and a rapid equity sell-off that exceeded that of the financial crisis, 55% of our AuM out-performed benchmarks in the March quarter.

 

"We are comforted by the evidence of our operational resilience in these testing times and, together with our diverse and complementary range of fund strategies with proven track records, we remain well positioned to deliver compelling returns for our clients and shareholders."

 

Polar Capital aims to announce its results for the financial year to 31 March 2020 on 22 June 2020.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Guy Wiehahn

Andrew Buchanan

 

+44 (0)20 7418 8893

 

Camarco

Ed Gascoigne-Pees

Monique Perks

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDIPMPTMTAMBFM
Date   Source Headline
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.